Overview: NGS Cataract Sequencing TestIntroduction: The NGS Cataract Sequencing Test sequences genes to diagnose hereditary cataracts, causing vision impairment. Following 2023 AAO guidelines, it uses PCR for high specificity, supporting vision screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in molecular pathology for patients with suspected hereditary cataracts.
Other Names: Cataract Assay, Hereditary Cataract Gene Test.
FDA Status: Laboratory-developed test (LDT), meeting molecular pathology standards for diagnostic accuracy.
Historical Milestone: Cataract sequencing began in the 2000s with vision disorder research. NGS methods improved in the 2010s, enhancing diagnostic precision.
Purpose: Sequences genes to diagnose hereditary cataracts, guides treatment, and evaluates patients with vision impairment.
Test Parameters: 1. Cataract Genes
Pretest Condition: No fasting required. Collect whole blood, buccal swab, or saliva. Report history of vision impairment, cataracts, or eye symptoms.
Specimen: Whole Blood (EDTA, 2-5 mL), Buccal Swab (sterile swab, 1-2 swabs), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document vision impairment, cataracts, glare sensitivity, or family history of cataracts. Include current medications, especially eye-related treatments.
Consent: Written consent required, detailing the tests purpose, cataract implications, and risks of sample collection.
Procedural Considerations: Uses next-generation sequencing to analyze cataract genes (e.g., CRYAA, CRYBB). Results are available in 3-5 days, supporting clinical decisions. Performed in laboratories, often for hereditary cataract diagnosis.
Factors Affecting Result Accuracy: Low DNA yield or improper sample storage can affect results. Contamination may reduce specificity.
Clinical Significance: Identified mutations confirm hereditary cataracts, guiding surgical intervention or genetic counseling. Negative results may require clinical evaluation.
Specialist Consultation: Consult an ophthalmologist or geneticist for result interpretation and treatment planning.
Additional Supporting Tests: Eye exam, slit-lamp examination, or visual acuity testing to confirm cataract diagnosis.
Test Limitations: Not all cataracts are hereditary; clinical correlation is needed. Sample quality affects sensitivity.
References: AAO Cataract Guidelines, 2023; Ophthalmology, Hejtmancik JF, 2022.
